Haleos Labs Limi

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE320X01016
  • NSEID: HALEOSLABS
  • BSEID: 540679
INR
1,302.10
-13 (-0.99%)
BSENSE

Dec 05

BSE+NSE Vol: 251

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
344.72
305.96
315.56
349.74
265.59
260.78
377.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
344.72
305.96
315.56
349.74
265.59
260.78
377.85
Raw Material Cost
149.91
150.19
171.33
204.47
135.17
147.04
268.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.15
0.97
0.08
-9.79
1.87
10.84
-12.92
Employee Cost
59.54
52.26
43.43
39.90
30.66
26.56
23.11
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
65.55
57.63
56.59
65.08
50.21
40.30
50.55
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
20.53
13.79
15.38
15.93
17.51
10.66
13.60
Total Expenditure (Excl Depreciation)
299.68
274.84
286.81
315.59
235.42
235.40
343.13
Operating Profit (PBDIT) excl Other Income
45.04
31.12
28.75
34.15
30.17
25.38
34.72
Other Income
4.86
3.83
3.07
2.07
1.78
2.28
2.55
Operating Profit (PBDIT)
49.90
34.95
31.82
36.22
31.95
27.66
37.27
Interest
8.71
10.16
6.79
6.17
4.53
5.14
5.51
Exceptional Items
0.00
0.00
2.35
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
41.19
24.79
27.38
30.05
27.42
22.52
31.76
Depreciation
15.00
14.94
10.79
10.01
7.86
7.86
6.38
Profit Before Tax
26.19
9.85
16.59
20.04
19.57
14.67
25.38
Tax
7.46
3.52
5.22
7.43
6.01
4.48
7.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.73
6.33
11.38
12.61
13.56
10.18
17.85
Extraordinary Items
0.00
0.00
0.00
12.69
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.73
6.33
11.38
25.30
13.56
10.18
17.85
Share in Profit of Associates
0.00
0.00
0.00
-0.02
0.00
0.00
0.00
Minority Interest
1.38
2.77
0.09
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.11
9.09
11.46
25.28
13.56
10.18
17.85
Equity Capital
3.02
3.02
3.02
3.02
3.02
3.02
3.02
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
193.54
173.79
165.59
149.21
126.19
112.71
103.31
Earnings per share (EPS)
66.59
30.1
37.95
83.71
44.9
33.71
59.11
Diluted Earnings per share
66.51
30.08
30.53
49.9
44.84
33.68
59.03
Operating Profit Margin (Excl OI)
13.07%
10.17%
9.11%
9.76%
11.36%
9.73%
9.19%
Gross Profit Margin
11.95%
8.1%
8.68%
8.59%
10.32%
8.64%
8.41%
PAT Margin
5.43%
2.07%
3.61%
3.61%
5.11%
3.9%
4.72%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 12.67% vs -3.04% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 121.23% vs -20.68% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 44.73% vs 8.24% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -14.27% vs 49.63% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Haleos Labs Limi With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
344.72
120.33
224.39
186.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
344.72
120.33
224.39
186.48%
Raw Material Cost
149.91
23.00
126.91
551.78%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.15
-0.31
4.46
1,438.71%
Employee Cost
59.54
54.27
5.27
9.71%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
65.55
0.00
65.55
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
20.53
48.36
-27.83
-57.55%
Total Expenditure (Excl Depreciation)
299.68
125.32
174.36
139.13%
Operating Profit (PBDIT) excl Other Income
45.04
-4.99
50.03
1,002.61%
Other Income
4.86
1.82
3.04
167.03%
Operating Profit (PBDIT)
49.90
-3.17
53.07
1,674.13%
Interest
8.71
4.09
4.62
112.96%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
41.19
-7.26
48.45
667.36%
Depreciation
15.00
4.98
10.02
201.20%
Profit Before Tax
26.19
-12.24
38.43
313.97%
Tax
7.46
1.72
5.74
333.72%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
18.73
-13.96
32.69
234.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
18.73
-13.96
32.69
234.17%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.38
-0.74
2.12
286.49%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.11
-14.70
34.81
236.80%
Equity Capital
3.02
12.03
-9.01
-74.90%
Face Value
10.00
10.00
0.00
Reserves
193.54
-2.54
196.08
7,719.69%
Earnings per share (EPS)
66.59
-12.22
78.81
644.93%
Diluted Earnings per share
66.51
-12.79
79.30
620.02%
Operating Profit Margin (Excl OI)
13.07%
-4.15%
0.00
17.22%
Gross Profit Margin
11.95%
-6.03%
0.00
17.98%
PAT Margin
5.43%
-11.60%
0.00
17.03%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 344.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.67% vs -3.04% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 20.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 121.23% vs -20.68% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 45.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 44.73% vs 8.24% in Mar 2024

Annual - Interest
Interest 8.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.27% vs 49.63% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.07%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024